[Federal Register Volume 59, Number 203 (Friday, October 21, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-26140]


[[Page Unknown]]

[Federal Register: October 21, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

Prime Vendor Program Information Meeting

AGENCY: Public Health Service, HHS.

ACTION: Notice of Prime Vendor Program Information Meeting.

-----------------------------------------------------------------------

SUPPLEMENTARY INFORMATION: Section 602 of Public Law 102-585, the 
``Veterans Health Care Act of 1992,'' enacted section 340B of the 
Public Health Service Act, ``Limitation on Prices of Drugs Purchased by 
Covered Entities.'' Section 340B provides that a manufacturer who sells 
covered outpatient drugs to eligible entities must sign an agreement 
with the Secretary of HHS in which the manufacturer agrees to charge a 
price for covered outpatient drugs that will not exceed an amount 
determined under a statutory formula.
    Currently, the Public Health Service (PHS) Drug Pricing Program has 
approximately 11,000 entities eligible to access section 340B discount 
pricing. These include certain Federally-qualified health centers, 
family planning projects, programs for AIDS patients, Black Lung 
clinics, Comprehensive hemophilia diagnostic and treatment centers, 
Native Hawaiian health centers, clinics treating tuberculosis and 
sexually transmitted diseases, and disaproportionate share hospitals. 
The names of these eligible entities are listed on the PHS Drug Pricing 
Computer Bulletin Board. To access this list of entities plus other 
program information (e.g., Federal Register notices and model discount 
calculations) call (301) 594-4992.
    Section 340B(a)(8) directs the Secretary to establish a prime 
vendor program under which eligible entities may enter into contracts 
with a prime vendor(s). The PHS is currently developing a prime vendor 
program which will include both drug price as well as drug distribution 
fee negotiating capability and anticipates entering into an agreement 
with an organization(s) to operate the program.
    The PHS will hold a meeting for all parties interested in 
submitting proposals to operate the prime vendor program. The purpose 
of the meeting is the disseminate necessary program information and to 
collect information concerning the number, various types, and relative 
capabilities of the interested parties.

FOR FURTHER INFORMATION CONTACT: Anyone interested in attending the 
meeting should contact CAPT William Matthews, Office of Drug Pricing, 
Bureau of Primary Health Care, 4350 East West Highway, West Tower, 10th 
Floor, Bethesda, MD, 20814, tel: (301) 594-0299.

DATE AND TIME: November 10, 1994, 10 a.m. to 12 p.m.

PLACE: Hyatt Regency Washington, 400 New Jersey Avenue NW., Washington, 
DC 20001, (202) 737-1234.

    Dated: October 18, 1994.
Ciro V. Sumaya,
Administrator, Health and Human Services.
[FR Doc. 94-26140 Filed 10-20-94; 8:45 am]
BILLING CODE 4160-15-M